[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Hypoglycemia - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 88 pages

Mumps - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 31 pages

Warts - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 111 pages

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020

US$ 2,000.00

... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 99 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 146 pages

Insulin Resistance - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 51 pages

Bacterial Vaginosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 72 pages

Degenerative Disc Disease - Pipeline Review, H1 2020

US$ 2,000.00

... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 68 pages

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2020

US$ 2,000.00

... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 86 pages

Plague - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 70 pages

Botulism - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 36 pages

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Opioid-Induced Constipation (OIC) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 53 pages

Lyme Disease - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 59 pages

Streptococcus pyogenes Infections - Pipeline Review, H1 2020

US$ 2,000.00

... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 35 pages

Community Acquired Pneumonia - Pipeline Review, H1 2020

US$ 2,000.00

... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 151 pages

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2020

US$ 2,000.00

... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 31 pages

Phenylketonuria (PKU) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 82 pages

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2020

US$ 2,000.00

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeli...

January 2020 62 pages

Cerebral Palsy - Pipeline Review, H1 2020

US$ 2,000.00

... . The Cerebral Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cerebral Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 47 pages

Autism - Pipeline Review, H1 2020

US$ 2,000.00

... . The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 177 pages

Down Syndrome - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 80 pages

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 35 pages

Otitis Media - Pipeline Review, H1 2020

US$ 2,000.00

... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 78 pages

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2020

US$ 2,000.00

... . The Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 107 pages

Urinary Incontinence - Pipeline Review, H1 2020

US$ 2,000.00

... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 74 pages

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 68 pages

Alopecia - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 190 pages

Colitis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 121 pages

Diarrhea - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 153 pages

Fatigue - Pipeline Review, H1 2020

US$ 2,000.00

... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 39 pages

Tourette Syndrome - Pipeline Review, H1 2020

US$ 2,000.00

... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 86 pages

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020

US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 197 pages

Alcohol Addiction - Pipeline Review, H1 2020

US$ 2,000.00

... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 183 pages

Ischemia Reperfusion Injury - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 177 pages

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 374 pages

Traumatic Brain Injury - Pipeline Review, H1 2020

US$ 2,000.00

... . The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 414 pages

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2020

US$ 2,000.00

... . The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 178 pages

Secondary Hyperparathyroidism - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Secondary Hyperparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 61 pages

House Dust Mite Allergy - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 58 pages

Iron Deficiency Anemia - Pipeline Review, H1 2020

US$ 2,000.00

... . The Iron Deficiency Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Iron Deficiency Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 95 pages

Sedation - Pipeline Review, H1 2020

US$ 2,000.00

... . The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 56 pages

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2020

US$ 2,000.00

... Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 87 pages

Intermittent Claudication - Pipeline Review, H1 2020

US$ 2,000.00

... pipeline guide Intermittent Claudication - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Intermittent Claudication (Cardiovascular), complete with analysis by stage of development ...

January 2020 55 pages

Myasthenia Gravis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Myasthenia Gravis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Myasthenia Gravis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 207 pages

Obsessive-Compulsive Disorder - Pipeline Review, H1 2020

US$ 2,000.00

... . The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 58 pages

Post-Operative Pain - Pipeline Review, H1 2020

US$ 2,000.00

... . The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 295 pages

Dilated Cardiomyopathy - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 58 pages

Left Ventricular Dysfunction - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 49 pages

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2020

US$ 2,000.00

... Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 42 pages

Nocturia - Pipeline Review, H1 2020

US$ 2,000.00

... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 46 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers